Get started
Author

Mohamed Kamal Shaker

Observed names: M K Shaker, M Shaker, M. K. Shaker, M. Shaker, MOHAMMED SHAKER, Mohamed K Shaker, Mohamed K. Shaker, Mohamed Shaker, Mohamed  Shaker, MohamedKamal Shaker, Mohammed Shaker
ORCID: 0000-0003-0199-074X
Observed ORCID: 0000-0003-0199-074X
OpenAlex ID: A5105351692
National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care
2017 · W. El‐Akel, M. H. El‐Sayed, et al. · Journal of Viral Hepatitis · 202
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
2014 · Amr El Fouly, Judith Ertle, et al. · Liver International · 132
Epidemiological characteristics of hepatocellular carcinoma in Egypt: a retrospective analysis of 1313 cases
2013 · Mohamed K. Shaker, Heba M. Abdella, et al. · Liver International · 89
Planning and prioritizing direct-acting antivirals treatment for HCV patients in countries with limited resources: Lessons from the Egyptian experience
2017 · Aisha Elsharkawy, Maissa El-Raziky, et al. · Journal of Hepatology · 75
Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
2013 · Omar Abdel-Rahman, Manal Abdel-Wahab, et al. · Medical Oncology · 54
Biliary complications including single-donor mortality: experience of 207 adult-to-adult living donor liver transplantations with right liver grafts
2010 · Mahmoud El-Meteini, Alaa Hamza, et al. · HPB · 35
Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
2017 · Mohamed K Shaker, Hanzada I Abdel Fattah, et al. · World Journal of Hepatology · 33
PDF
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
2023 · Ashraf Omar, Ahmed Kaseb, et al. · Journal of Hepatocellular Carcinoma · 25
PDF
Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
2013 · Omar Abdel-Rahman, Manal Abdelwahab, et al. · Journal of the Egyptian National Cancer Institute · 25
PDF
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
2018 · Hamdy Azim, Ashraf Omar, et al. · Journal of Hepatocellular Carcinoma · 22
PDF
Characteristics of hepatocellular carcinoma in Egyptian patients with primary Budd‐Chiari syndrome
2016 · Mohammad Sakr, Sara M. Abdelhakam, et al. · Liver International · 18
Extrahepatic metastases as initial manifestations of hepatocellular carcinoma: an Egyptian experience
2015 · Thanaa El. A. Helal, Nehal A. Radwan, et al. · Diagnostic Pathology · 18
PDF
Portal venous and hepatic artery hemodynamic variation in non-alcoholic fatty liver disease
2021 · Manal Sabry, Tarek Youssef, et al. · Egyptian Liver Journal · 15
PDF
Delta virus infection in Egypt.
1992 · M A Darwish, M Shaker, et al. · PubMed · 15
Venous malformations of the head and neck: A diagnostic approach and a proposed management approach based on clinical, radiological, and histopathology findings
2013 · Yasser Abdallah Aboelatta, Eman Nagy, et al. · Head & Neck · 14
Validation of prognostic indices in Egyptian Budd-Chiari syndrome patients: A single-center study
2017 · Mohammad Sakr, Sara M Abdelhakam, et al. · World Journal of Gastroenterology · 13
PDF
Epidemiology of HCC in Egypt
2016 · Mohamed  Shaker · Gastroenterology & Hepatology Open Access · 13
PDF
Risk factors for early intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma in E gyptian patients
2014 · Mohammed Fawzy Montasser, Mohamed Kamal Shaker, et al. · Journal of Digestive Diseases · 13
Direct-acting antiviral regimens in Egyptian patients with chronic hepatitis C virus infection: A real-world single-center experience
2021 · Gina Gamal Naguib, Amir Farid, et al. · Arab Journal of Gastroenterology · 10
Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma
2021 · Tamer Elbaz, Imam Waked, et al. · Expert Review of Anti-infective Therapy · 10
Evaluation of Golgi Protein 73 (GP73) as a Potential Biomarkers for Hepatocellular Carcinoma
2020 · Mohammed Shaker, Fadia Attia, et al. · Clinical Laboratory · 10
Hepatitis B & D viral infections among schistosomal patients in Egypt.
1992 · M A Darwish, M Shaker, et al. · PubMed · 9
Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
2018 · Mohamed Kamal Shaker, Iman Montasser, et al. · Journal of Hepatocellular Carcinoma · 7
PDF
Outcome of transarterial chemoembolization in Egyptian patients with hepatocellular carcinoma and branch portal vein thrombosis
2018 · H. Abdella, M. K. Shaker, et al. · Indian Journal of Gastroenterology · 5
Feasibility of Anticoagulation in Patients of Budd-chiari Syndrome with Gastroesophageal Varices and Portal Hypertension
2013 · Hany Dabbous, Mohamed Sakr, et al. · Journal of Gastroenterology and Hepatology Research · 5
Works count: 54
Citation count: 933
H-index: 15
I10-index: 22
Year
Topic
Type